Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Pemetrexed · Alimta, Pemfexy

Small molecule · Inhibitor of thymidylate synthase (TYMS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GART) · developed by Lilly

Approved FDA, Aug 2004

What is Pemetrexed?

Pemetrexed is a folate analog metabolic inhibitor that is taken up into cells and converted to polyglutamate forms, which inhibit thymidylate synthase and GARFT. It also inhibits dihydrofolate reductase, blocking de novo synthesis of thymidine and purine nucleotides needed for cell replication. It is used in non-squamous non-small cell lung cancer and malignant pleural mesothelioma, and is studied in ovarian cancer, urothelial cancer and other solid tumors.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Alimta, Pemfexy
Drug type
Small molecule
Targets
thymidylate synthase (TYMS), dihydrofolate reductase (DHFR), glycinamide ribonucleotide formyltransferase (GART)
Mechanism
Inhibitor of thymidylate synthase (TYMS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GART)
Pathways
de novo thymidine and purine nucleotide biosynthesis, folate-dependent metabolism
Therapy area
Oncology
Developer
Lilly
In trials of
PFE
FDA status
Approved as Alimta, Pemfexy (August 19, 2004), NDA021677 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Feb 20, 2026). Read the full label for the exact wording, limitations and safety information.

Conditions studied

Advanced MalignanciesNSCLCOvarian CancerSolid TumorsUrothelial Cancer

Other drugs acting on TYMS / DHFR / GART

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.